Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE The TP53 Arg 72 Pro polymorphism has been reported to be a risk factor for several types of cancer, but its association with pancreatic cancer has not been fully evaluated. 21468597

2011

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Of them, a nonsynonymous polymorphism, Arg72Pro (rs1042522 C>G), has been most extensively studied for the association with cancer risk; however, few studies have investigated its effect on Wilms' tumor. 28260929

2017

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Codon 72 exon 4 polymorphism (Arg72Pro) of the p53 gene has been implicated in cancer risk. 15633234

2005

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Various studies have evaluated the association between p53 codon 72 G > C (rs1042522) polymorphism and risk of cancer. 24863946

2014

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE The <i>TP53</i> Arg72Pro (rs1042522 C>G) polymorphism has been reported to be associated with the risk of several types of adult cancers; however, its risk for pediatric cancers remains unclear. 31293648

2019

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE The aim of this report is to determine frequencies and associations of p53 codon 72 arg/pro polymorphism with different types of cancer in Sudan. p53 codon72 arg/pro polymorphism distribution and allele frequencies in 264 samples of different types of cancers were investigated using PCR. 23053979

2012

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Among various polymorphic variants of TP53 gene, codon 72 polymorphism (Arg72Pro) has been found to be associated with cancer susceptibility, but only few studies have investigated their effect on bladder cancer risk. 21156242

2010

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE The p53 Arg72Pro single-nucleotide polymorphism (SNP) was found to be associated with an increased risk of various malignancies. 21778786

2011

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis. 26320432

2015

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE TP53 Arg72Pro polymorphism has been proposed to have some effects on host's susceptibility to cancer. 24375191

2014

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE The Arg72Pro substitution did not associate with decreased risk of cancer. 17535973

2007

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Analysis of TP53 (rs1042522) showed a significantly higher frequency in cancer samples (OR=1.22, 95%CI=1.004-1.481, p-value=0.016) while differences in frequency were not significant within each group (p-value=0.070). 23534750

2013

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE R72P associations with specific cancer risk, particularly hematological malignancies, have been conflicting. 25768405

2015

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE In conclusion, the p73 G4C14-to-A4T14 homozygous variant genotype might be a risk factor for cancer, especially in combination with the p53 exon 4 Arg72Pro polymorphism. 21976716

2012

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Among various polymorphic variants of TP53 gene, codon 72 polymorphism (Arg72Pro) has been found to be associated with cancer susceptibility, but only few studies have investigated their effect on thyroid cancer risk. 25835179

2015

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE TP53 Arg72Pro (rs1042522 C > G) and miR-34b/c rs4938723 (T > C) polymorphisms have been known to modify cancer susceptibility. 31325764

2019

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Statistically significant associations were noted between SNPs in beta-catenin and APOE and a positive family history of cancer (beta-catenin: p=0.034, APOE: p=0.033); tumor location and a DCC SNP (p=0.038) and the P53 R72P mutation and survival (p=0.0336). 15523694

2005

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. 16721787

2006

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE In conclusion, the TP53 gene Arg72Pro polymorphism appreciably influence on occurrence of chromosome aberrations in cancer. 20512840

2010

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE From other HPV-related malignancies a link between a functional SNP in the p53 gene (rs1042522, p.Arg72Pro) and a higher disease risk in the presence of HPV is documented. 30519324

2018

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Thus, it is evident from our study that Arg72Pro SNP is implicated in kangri cancer and that the rare, proline-related allele is connected with higher susceptibility to kangri cancer. 22249977

2012

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Meta-analysis of associations between ATM Asp1853Asn and TP53 Arg72Pro polymorphisms and adverse effects of cancer radiotherapy. 25605158

2014

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Risk of cancer</span> specific mortality, cardiovascular mortality, and respiratory mortality were not associated with Arg72Pro genotype overall; however, in exploratory subgroup analyses, genotype-associated risks of malignant melanoma and diabetes were altered. 28336930

2017

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE Moreover, increased cancer risks were observed for the TP53 Arg72Pro polymorphism in patients with poorly differential status, clinical stage II, and without lymph node metastasis. 26619844

2016

dbSNP: rs1042522
rs1042522
0.100 GeneticVariation BEFREE A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. 16419081

2006